• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过级联脱氧核糖核酸编码文库筛选方法发现和优化 WD40 重复蛋白 5 抑制剂。

Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach.

机构信息

School of Chinese Materia Medica, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, China.

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China.

出版信息

J Med Chem. 2024 Jan 25;67(2):1079-1092. doi: 10.1021/acs.jmedchem.3c01463. Epub 2024 Jan 3.

DOI:10.1021/acs.jmedchem.3c01463
PMID:38166388
Abstract

The DNA-encoded library (DEL) is a powerful hit generation tool for chemical biology and drug discovery; however, the optimization of DEL hits remained a daunting challenge for the medicinal chemistry community. In this study, hit compounds targeting the WIN binding domain of WDR5 were discovered by the initial three-cycle linear DEL selection, and their potency was further enhanced by a cascade DEL selection from the focused DEL designed based on the original first run DEL hits. As expected, these new compounds from the second run of focused DEL were more potent WDR5 inhibitors in the protein binding assay confirmed by the off-DNA synthesis. Interestingly, selected inhibitors exhibited good antiproliferative activity in two human acute leukemia cell lines. Taken together, this new cascade DEL selection strategy may have tremendous potential for finding high-affinity leads against WDR5 and provide opportunities to explore and optimize inhibitors for other targets.

摘要

DNA 编码文库 (DEL) 是化学生物学和药物发现的强大命中生成工具;然而,DEL 命中的优化仍然是药物化学界面临的艰巨挑战。在这项研究中,通过初始的三轮线性 DEL 选择发现了针对 WDR5 的 WIN 结合域的命中化合物,并且通过基于原始第一轮 DEL 命中设计的聚焦 DEL 进行级联 DEL 选择进一步提高了它们的效力。正如预期的那样,这些来自第二轮聚焦 DEL 的新化合物在蛋白质结合测定中是更有效的 WDR5 抑制剂,这一点通过非 DNA 合成得到了证实。有趣的是,所选抑制剂在两种人急性白血病细胞系中表现出良好的增殖抑制活性。总之,这种新的级联 DEL 选择策略可能具有发现针对 WDR5 的高亲和力先导化合物的巨大潜力,并为探索和优化其他靶标抑制剂提供机会。

相似文献

1
Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach.通过级联脱氧核糖核酸编码文库筛选方法发现和优化 WD40 重复蛋白 5 抑制剂。
J Med Chem. 2024 Jan 25;67(2):1079-1092. doi: 10.1021/acs.jmedchem.3c01463. Epub 2024 Jan 3.
2
Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction.WDR5与MYC相互作用的强效小分子抑制剂的发现。
ACS Chem Biol. 2023 Jan 20;18(1):34-40. doi: 10.1021/acschembio.2c00843. Epub 2023 Jan 3.
3
Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets.利用片段的 DNA 编码文库进行具有挑战性的治疗靶目标的命中发现。
Expert Opin Drug Discov. 2024 Jun;19(6):725-740. doi: 10.1080/17460441.2024.2354287. Epub 2024 May 16.
4
Exploring the Lower Limit of Individual DNA-Encoded Library Molecules in Selection.在选择中探索个体 DNA 编码文库分子的下限。
SLAS Discov. 2020 Jun;25(5):523-529. doi: 10.1177/2472555219893949. Epub 2019 Dec 20.
5
Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization.基于药效团的优化发现有效的口服生物利用度 WD 重复结构域 5(WDR5)抑制剂。
J Med Chem. 2022 Apr 28;65(8):6287-6312. doi: 10.1021/acs.jmedchem.2c00195. Epub 2022 Apr 18.
6
Evolution of the Selection Methods of DNA-Encoded Chemical Libraries.DNA 编码化学库的选择方法的演变。
Acc Chem Res. 2021 Sep 7;54(17):3491-3503. doi: 10.1021/acs.accounts.1c00375. Epub 2021 Aug 24.
7
The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.通过基于荧光偏振的高通量筛选鉴定靶向 WDR5-MLL1 相互作用的新型小分子抑制剂。
Bioorg Med Chem Lett. 2019 Feb 15;29(4):638-645. doi: 10.1016/j.bmcl.2018.12.035. Epub 2018 Dec 17.
8
Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core.发现并基于结构优化含有二氢异喹啉酮双环核心的强效和选择性 WD 重复结构域 5(WDR5)抑制剂。
J Med Chem. 2020 Jan 23;63(2):656-675. doi: 10.1021/acs.jmedchem.9b01608. Epub 2020 Jan 7.
9
Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library.从以蛋白酶为重点的 DNA 编码化学库中发现有效的凝血酶抑制剂。
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):16782-16789. doi: 10.1073/pnas.2005447117. Epub 2020 Jul 8.
10
Discovery Small-Molecule p300 Inhibitors Derived from a Newly Developed Indazolone-Focused DNA-Encoded Library.从新开发的吲唑酮为重点的 DNA 编码文库中发现小分子 p300 抑制剂。
Bioconjug Chem. 2024 Aug 21;35(8):1251-1257. doi: 10.1021/acs.bioconjchem.4c00307. Epub 2024 Aug 8.